The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

J.L. Hayward, Paul P. Carbone, S Kumaoka et al. · Cancer · 1977 · 627 citations · Full text

Medicine, Oncology, Breast Oncology +15

ASSESSMENT OF RESPONSE TO TREATMENT IN ADVANCED BREAST CANCER

E A Benson · The Lancet · 1974 · 80 citations

Medicine, Oncology, Breast Oncology +8

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist

Robert I. Nicholson, Paul V. Maynard · British Journal of Cancer · 1979 · 52 citations

Medicine, Oncology, Pharmacology +9

THERAPEUTIC CASTRATION VERSUS PROPHYLACTIC CASTRATION IN BREAST CANCER.

Kennedy Bj, Mielke Pw, Fortuny Ie · PubMed · 1964 · 43 citations

Medicine, Oncology, Surgery +10

Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments

Jan G.M. Klijn · Medical Oncology and Tumor Pharmacotherapy · 1984 · 41 citations

Medicine, Oncology, Pharmacology +17